Susan J. Knox
Corporate Officer/Principal chez Stanford University
Profil
Susan J.
Knox is the founder of EpicentRx, Inc. She is currently an Associate Professor at Stanford University.
Previously, she worked as a Consultant at InterWest Partners LLC.
Dr. Knox holds a doctorate degree from Stanford University and the University of California, Davis, and an undergraduate degree from the University of California, Berkeley.
Postes actifs de Susan J. Knox
Sociétés | Poste | Début |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
Anciens postes connus de Susan J. Knox
Sociétés | Poste | Fin |
---|---|---|
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Fondateur | - |
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Consultant / Advisor | - |
Formation de Susan J. Knox
Stanford University | Doctorate Degree |
University of California, Berkeley | Undergraduate Degree |
University of California, Davis | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 2 |
---|---|
InterWest Partners LLC
InterWest Partners LLC Investment ManagersFinance InterWest Partners LLC (InterWest Partners) is a venture capital firm founded in 1979 by Wally Hawley, Scott Hedrick and Gene Barth. The firm is headquartered in San Francisco, California. | Finance |
EpicentRx, Inc.
EpicentRx, Inc. Pharmaceuticals: MajorHealth Technology EpicentRx, Inc. develops compounds sourced and adapted from the aerospace industry for treating cancer. Its technology includes chemical platform, RRx-001 overview, rons potential, epigenetics, collaboration and immunotherapy. The company was founded by Susan J. Knox and Mark Bednarski and is headquartered in Mountain View, CA. | Health Technology |